NEW YORK, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- American Oriental
Bioengineering, Inc. (NYSE: AOB) ("AOBO"), a leading marketer, distributor
and manufacturer of pharmaceutical and healthcare products in China, today
announced that the Company will present at the following conferences:
-- Oppenheimer 19th Annual Healthcare Conference, held at the Waldorf-
Astoria in New York. Management is currently scheduled to present at
8:40 am ET on Tuesday, November 4, 2008.
-- Credit Suisse Asia Healthcare Conference, held at the Westin in Beijing.
Management is currently scheduled to present at 4:30 pm local time on
Wednesday, November 5, 2008;
-- Morgan Stanley 2008 Asia Pacific Summit, held at the Mandarin Oriental
in Singapore. Management is currently scheduled to present at 3:15 pm
local time on Wednesday, November 12, 2008;
-- Oppenheimer 4th Annual 'Best Ideas' Conference, held at the Millennium
Broadway in New York. Management is currently scheduled to present at
1:20 pm ET on Tuesday, November 18, 2008. A webcast of this
presentation will be available via the Company's website at
-- Lazard 5th Annual Healthcare Conference, held at the St. Regis in New
York. Management is currently scheduled to present at 11:30 am ET on
Wednesday, November 19, 2008.
For more details on the conferences, please contact your respective institutional sales representative.
About American Oriental Bioengineering Inc.
American Oriental Bioengineering Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.
Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other factors identified in the Company's filings with the Securities and Exchange Commission, including the Form 10-Q for the quarter ended June 30, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.
|SOURCE American Oriental Bioengineering Inc.|
Copyright©2008 PR Newswire.
All rights reserved